Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04138680 · ClinicalTrials.gov registry record · NA
Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT04138680 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 79 participants.
The verdict
NCT04138680, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Previous research has shown that modulation of a brain region in rodents, the ventral tegmental area (VTA), improves depressive symptoms. Human research has also shown that VTA self-modulation using 'biofeedback' is feasible and successful in healthy volunteers. This biofeedback procedure is a type of cognitive training that includes real-time feedback about brain signal levels from the VTA. Our question is whether VTA self-modulation with biofeedback can influence depression symptoms.
Interventions
- BEHAVIORAL Active Biofeedback
- BEHAVIORAL Sham Biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2019-10-09 |
| Est. Completion | 2024-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04138680
The ClinicalTrials.gov registry entry for NCT04138680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Biofeedback is the first listed.
NCT04138680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04138680 about?
NCT04138680 is a clinical study titled "Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression". Previous research has shown that modulation of a brain region in rodents, the ventral tegmental area (VTA), improves depressive symptoms. Human research has also shown that VTA self-modulation using 'biofeedback' is feasible and successful in healthy volunteers. This biofeedback procedure is a type ...
What is the current status of trial NCT04138680?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2019-10-09. Estimated completion is 2024-06-11.
What interventions are being tested in trial NCT04138680?
The interventions under investigation include: Active Biofeedback (BEHAVIORAL), Sham Biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT04138680?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.